NASDAQ: QLI - Qilian International Holding Group Limited

Доходность за полгода: -10.14%
Дивидендная доходность: 0.00%
Сектор: Healthcare

График акции Qilian International Holding Group Limited


О компании Qilian International Holding Group Limited

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.

подробнее
It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

IPO date 2021-01-12
ISIN KYG7307E1070
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.25
Сайт https://ir.qlsyy.net
Цена ао 7.18
Изменение цены за день: 0% (7.18)
Изменение цены за неделю: 0% (7.18)
Изменение цены за месяц: 0% (7.18)
Изменение цены за 3 месяца: 0% (7.18)
Изменение цены за полгода: -10.14% (7.99)
Изменение цены за год: +940.58% (0.69)
Изменение цены за 3 года: +310.29% (1.75)
Изменение цены с начала года: 0% (7.18)

Недооценка

Название Значение Оценка
P/S 2.96 6
P/BV 3.09 5
P/E 127.83 1
EV/EBITDA -89.12 0
Итого: 3.88

Эффективность

Название Значение Оценка
ROA, % -15.18 0
ROE, % -18.18 0
Итого: 0

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0.5 5
Итого: 3.57

Долг

Название Значение Оценка
Debt/EBITDA -0.3939 10
Итого: 8.2

Импульс роста

Название Значение Оценка
Доходность Revenue, % 0.8058 1
Доходность Ebitda, % -117.46 0
Доходность EPS, % -242.81 0
Итого: 2.2

Институционалы Объем Доля, %
Geode Capital Management, LLC 23641 0.07
UBS Group AG 3357 0.01
Morgan Stanley 1794 0.01



Руководитель Должность Оплата Год рождения
Mr. Zhanchang Xin Chairman of the Board, President, COO & Chief Scientific Officer 17.94k 1967 (58 лет)
Mr. Chen Xin Chief Executive Officer 1993 (32 года)
Ms. Yaxuan Zhai Chief Financial Officer 1995 (30 лет)

Адрес: China, Jiuquan, Jiuquan Economic and Technological Development Zone - открыть в Google картах, открыть Яндекс картах
Сайт: https://ir.qlsyy.net